ScholarIQanswers from OpenAlex

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

PaperCitations, authors & open-access status

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes have?

ScholarIQcitation count

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes has 797 citations in the OpenAlex counts ScholarIQ stores.

When was Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes published?

ScholarIQyear

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes has 2005 year in the ScholarIQ index.

What is the open-access status of Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes?

ScholarIQoa status

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes has closed oa status in the ScholarIQ index.

What is the DOI of Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes?

ScholarIQdoi

The DOI for Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes is on the source record.

What is the PMID of Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes?

ScholarIQpmid

The PMID for Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes is on the source record.

What is the OpenAlex record for Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes?

ScholarIQopenalex

The OpenAlex for Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial